Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 09 - 12 symbols : Amgn save search
Recombinant Proteins Market Size worth USD 633.23 Mn by 2026, Market Analysis Segmented by Application and Geography - Technavio
Published: 2022-09-12 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.72%
H: 0.07%
C: -1.27%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.97%
H: 0.16%
C: -0.98%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
ABCM | $23.99 0.0% 7.4M
|
Health Technology
|
| O: 0.06%
H: 0.83%
C: 0.06%
application market
AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
Published: 2022-09-12 (Crawled : 22:00) - biospace.com/
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
america global conference
Entera Bio to Present at H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-12 (Crawled : 21:00) - globenewswire.com
ENTX | $1.985 -11.38% -12.85% 300K
|
Health Technology
|
| O: 0.71%
H: 0.72%
C: -1.42%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
global conference
Entera Bio Presents Dose Proportional Absorption and Correlation to BMD Clinical Response Data from its Phase 2 Study of EB613 in Post-Menopausal Osteoporosis Patients at the ASBMR 2022 Annual Meeting
Published: 2022-09-12 (Crawled : 11:00) - globenewswire.com
ENTX | $1.985 -11.38% -12.85% 300K
|
Health Technology
|
| O: 0.72%
H: 6.43%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
eb613 correlation meeting response study osteoporosis
LUMAKRAS® (SOTORASIB) COMBINED WITH VECTIBIX® (PANITUMUMAB) SHOWS CONFIRMED 30% OBJECTIVE RESPONSE RATE IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2022-09-12 (Crawled : 09:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.6%
H: 1.16%
C: 0.17%
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: -0.16%
H: 0.16%
C: 0.06%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -1.88%
H: 3.78%
C: 3.73%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
lumakras response cancer
Celiac Diseases Drugs Market Report by Technavio expects growth to accelerate at 16.95% CAGR
Published: 2022-09-12 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.56%
H: 9.43%
C: 7.62%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.78%
H: 0.58%
C: 0.58%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.44%
H: 1.67%
C: 0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
BLRX | $0.6564 2.55% 2.48% 190K
|
Health Technology
|
| O: -3.3%
H: 1.7%
C: -6.82%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
report growth market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.